510(k) Report

PMA · Approved

Approved

FX Minirail RX Percutaneous Transluminal Coronary Angioplasty (Ptca) Catheter

P020037PMAApproved Jun 11, 2003274-day reviewClass II21 CFR 870.5100

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Abbott Vascular, Inc. · LOX Catheters, Transluminal Coronary Angioplasty, Percutaneous

Approved on Jun 11, 2003 through premarket approval, which rests on the device’s own clinical evidence after a 274-day review. 1 later device descends from it.

Decided
Jun 11, 2003
Review
274 days
Class
Class II
Product code
LOX
Recalls
None

1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2013: 1 descendant cleared200020052010201520202025
  1. This deviceP020037 FX Minirail RX Percutaneous Transluminal Coronary Angioplasty (Ptca)…Abbott Vascular, Inc. · 2003
  2. Descendant · cites it directly · 0 of its ownK123473 Hoper Ptca Balloon CatheterLepu Medical Technology (Beijing) Co., Ltd. · 2013

Most influential descendants

Showing 1 of 1 · See all
  • K123473Hoper Ptca Balloon CatheterLepu Medical Technology (Beijing) Co., Ltd. · 2013 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)P020037FX Minirail RX Percutaneous Transluminal Coronary Angioplasty (Ptca) CatheterAbbott Vascular, Inc.2003—
+1K123473Hoper Ptca Balloon CatheterLepu Medical Technology (Beijing) Co., Ltd.2013—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201310
FIG. 1 — Lineage of P020037, 2003–2013Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LOX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LOX device

  1. #1 K254022 FLASH Flex™ Aorto-Ostial Angioplasty Systemscore 12.3 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K123473Hoper Ptca Balloon CatheterLepu Medical Technology (Beijing) Co., Ltd.20130

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K123473 (Lepu Medical Technology (Beijing) Co., Ltd., 2013) has gone furthest, with 0 descendants of its own.

How does its category compare?

All LOX devices

LOX Catheters, Transluminal Coronary Angioplasty, Percutaneous: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LOX

4in 2024

2007: 192008: 222009: 282010: 322011: 92012: 102013: 62014: 62015: 42016: 92017: 62018: 72019: 12020: 12021: 62022: 52023: 42024: 42026 (partial year): 6
2007high 32 (2010) · low 0 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LOX

241in 2024

2011: 103 days median2012: 120 days median2013: 123 days median2014: 166 days median2015: 119 days median2016: 116 days median2017: 113 days median2018: 80 days median2021: 167 days median2022: 121 days median2023: 138 days median2024: 241 days median2026 (partial year): 156 days median
2007high 241 (2024) · low 80 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LOX

4in 2019

2007: 12008: 802019: 4
2007high 80 (2008) · low 0 (2009)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LOX

1,890in 2025

2007: 1,0532008: 1,0632009: 1,3532010: 1,3922011: 2,0902012: 2,0922013: 2,4362014: 2,3162015: 2,0602016: 2,5782017: 2,7532018: 2,2252019: 2,1022020: 1,9742021: 1,7382022: 1,8162023: 1,7202024: 1,8042025: 1,890
2007high 2,753 (2017) · low 1,053 (2007)2025

MAUDE reports naming product code LOX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200719—11,053
200822—801,063
200928—01,353
201032—01,392
2011910302,090
20121012002,092
2013612302,436
2014616602,316
2015411902,060
2016911602,578
2017611302,753
201878002,225
20191—42,102
20201—01,974
2021616701,738
2022512101,816
2023413801,720
2024424101,804
20250—01,890
202661560—
Cite this page

510(k) Report. “P020037: FX Minirail RX Percutaneous Transluminal Coronary Angioplasty (Ptca) Catheter.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/P020037

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026